,28,29,30 Therefore, our approach was to use ARV as a BRD4 selective PROTAC and PTEN plasmid as a tumor suppressor gene for simultaneous indirect inhibition of c-Myc expression in VEM-resistant melanoma. The gene discussed is PTEN; the disease is melanoma.